Literature DB >> 20075755

Predictive factors of postoperative pulmonary complications in scoliotic patients with moderate or severe pulmonary dysfunction.

Jinqian Liang1, Guixing Qiu, Jianxiong Shen, Jianguo Zhang, Yipeng Wang, Shugang Li, Hong Zhao.   

Abstract

STUDY
DESIGN: Retrospective clinical study.
OBJECTIVE: To evaluate the predictive factors of postoperative pulmonary complications in unselected scoliotic patients with moderate or severe pulmonary dysfunction.
BACKGROUND: Many scoliotic patients with moderate or severe pulmonary dysfunction develop postoperative pulmonary complications during hospitalization. However, little is reported about the postoperative pulmonary complication events in this population at the first visit to the hospital.
METHODS: A total of 88 scoliotic patients with moderate or severe pulmonary dysfunction were identified. The demographic distribution, medical history, and clinical data were collected to investigate the predictive factors of immediate postoperative pulmonary complications by logistic regression.
RESULTS: A total of 16 (18.2%) patients were documented with postoperative pulmonary complications including increased requirement of postoperative ventilatory support (6.3%), atelectasis (31.3%), pneumothorax (6.3%), pneumonia (12.5%), and hypoxemia (43.8%). There were no statistical differences in age, sex, body mass index, abnormal echocardiogram, and prior symptoms between the 2 groups (P>0.05). Of the patients with postoperative pulmonary complications, a slightly higher proportion of patients underwent anterior approach, 2 (12.5%) versus 2 (2.8%) (P=0.091). The Cobb angle before surgery was 102.1+/-25.5 degree with postoperative pulmonary complications versus 87.7+/-23.8 degree without postoperative pulmonary complications (P=0.034). Forced vital capacity was 47.0+/-10.5% versus 52.4+/-9.0% (P=0.037). Number of levels fused was 13.7+/-2.3 versus 13.1+/-2.2 (P=0.319). Operation time was 376.8+/-125.6 minutes versus 350.4+/-97.8 minutes (P=0.357). Anesthesia time was 415.3+/-126.8 minutes versus 388.0+/-97.5 minutes (P=0.341). Estimated blood loss was 1050.0+/-769.4 mL versus 777.8+/-460.9 mL (P=0.065), respectively. Logistic regression analysis showed that thoracoplasty correlated with postoperative pulmonary complications (odds ratio 3.81, 95% confidence interval 1.11-13.16).
CONCLUSIONS: Thoracoplasty is the only independent predictor of postoperative pulmonary complications. However, the abnormal echocardiogram, prior symptoms, forced vital capacity, and other clinical characteristics play a less relevant role in the prediction of postoperative pulmonary complications.

Entities:  

Mesh:

Year:  2010        PMID: 20075755     DOI: 10.1097/BSD.0b013e3181b55ff4

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  10 in total

1.  Risk factors for postoperative pulmonary complications in the treatment of non-degenerative scoliosis by posterior instrumentation and fusion.

Authors:  Yunsheng Wang; Yong Hai; Yuzeng Liu; Li Guan; Tie Liu
Journal:  Eur Spine J       Date:  2019-04-08       Impact factor: 3.134

2.  The influence of isolated thoracoplasty on the evolution of pulmonary function after treatment of severe thoracic scoliosis.

Authors:  Heiko Koller; Tobias L Schulte; Oliver Meier; Juliane Koller; Viola Bullmann; Wolfgang Hitzl; Michael Mayer; Tobias Lange; Jens Schmücker
Journal:  Eur Spine J       Date:  2017-02-08       Impact factor: 3.134

Review 3.  The impact of halo-gravity traction on curve rigidity and pulmonary function in the treatment of severe and rigid scoliosis and kyphoscoliosis: a clinical study and narrative review of the literature.

Authors:  Heiko Koller; Juliane Zenner; Vera Gajic; Oliver Meier; Luis Ferraris; Wolfgang Hitzl
Journal:  Eur Spine J       Date:  2011-11-01       Impact factor: 3.134

4.  The role of preoperative pulmonary function tests in the surgical treatment of extremely severe scoliosis.

Authors:  Lifeng Lao; Xisheng Weng; Guixing Qiu; Jianxiong Shen
Journal:  J Orthop Surg Res       Date:  2013-09-05       Impact factor: 2.359

5.  Postoperative pulmonary complications following posterior spinal instrumentation and fusion for congenital scoliosis.

Authors:  Si Yin; Huiren Tao; Heng Du; Chaoshuai Feng; Yimin Yang; Weizhou Yang; Chunguang Duan
Journal:  PLoS One       Date:  2018-11-16       Impact factor: 3.240

6.  Peri-operative management of children with spinal muscular atrophy.

Authors:  Matthew A Halanski; Andrew Steinfeldt; Rewais Hanna; Scott Hetzel; Mary Schroth; Bridget Muldowney
Journal:  Indian J Anaesth       Date:  2020-11-01

7.  Risk factors of postoperative pulmonary complications after primary posterior fusion and hemivertebra resection in congenital scoliosis patients younger than 10 years old: a retrospective study.

Authors:  Xuerong Yu; Jianguo Zhang; Lulu Ma; Jianxiong Shen; Yu Zhao; Shugang Li; Yuguang Huang
Journal:  BMC Musculoskelet Disord       Date:  2022-01-26       Impact factor: 2.362

8.  Postoperative Pulmonary Complications in Complex Pediatric and Adult Spine Deformity: A Retrospective Review of Consecutive Patients Treated at a Single Site in West Africa.

Authors:  Irene Wulff; Henry Ofori Duah; Henry Osei Tutu; Gerhard Ofori-Amankwah; Kwadwo Poku Yankey; Mabel Adobea Owiredu; Halima Bidemi Yahaya; Harry Akoto; Audrey Oteng-Yeboah; Oheneba Boachie-Adjei
Journal:  Global Spine J       Date:  2020-08-10

9.  Intraoperative tension pneumothorax during posterior vertebral column resection in a child with congenital scoliosis.

Authors:  Abolfazl Rahimizadeh; Valiollah Hassani; Nima Mohsenikabir; Ava Rahimizadeh; Mona Karimi; Naser Asgari
Journal:  Surg Neurol Int       Date:  2019-08-02

10.  Effectiveness and safety of a modified (rib ends fixed under transverse process) thoracoplasty for rib hump deformity in adults with severe thoracic scoliosis: A retrospective study.

Authors:  Bin Yu; Deng Zhao; Fei Wang; Zhengjun Hu; Rui Zhong; Hehong Zhao; Yijian Liang
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.